Article
Tumor suppressor gene inactivation in myeloid malignancies.
Best practice & research. Clinical haematology - 1 Dec 2008
Wong Jasmine C, Le Beau Michelle M, Shannon Kevin
Abstract excerpt
Our molecular understanding of the how tumor suppressor gene (TSG) abnormalities contribute to myeloid malignancies is relatively limited. While the NF1 and TP53 TSGs follow the Knudson two-hit paradigm and undergo biallelic inactivation, there is increasing evidence that inactivation of a single allele of TSG such as RUNX1, PU.1 and RPS14 (haploinsufficiency) can also contribute to leukemogenesis. New...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
